abundant protease inhibitor plasma archetype serine protease inhibitor superfamily genetic variants human associated emphysema liver cirrhosis detailed molecular mechanism pathogenicity variant molecules known examined structural basis dozen deficient variants unlike variants unstable d256v l41p variants exhibited extremely retarded protein folding compared molecule folded stability inhibitory activity variant proteins comparable molecule retarded protein folding promote protein aggregation allowing accumulation folding intermediates repeated observations retarded protein folding indicate important mechanism causing deficiency variant molecules fold metastable native form functional alpha1 antitrypsin alpha1 antitrypsin early onset alpha1 antitrypsin alpha1 antitrypsin alpha1 antitrypsin wild type wild type aggregation prone alpha1 antitrypsin